Dr. Pamela Tenaerts
As Executive Director of the Clinical Trials Transformation Initiative (CTTI), Dr. Tenaerts implements strategies to accomplish CTTI’s mission to improve quality and efficiency of clinical trials by engaging all stakeholders equally. Dr. Tenaerts practiced medicine in the emergency department and private practice setting. She served as the European coordinator of the GUSTO study at the K.U. Leuven, and later as the North American coordinator at Duke University Medical Center. Subsequently, she held a position at Sarasota Memorial Hospital, where she directed a multi-specialty centralized clinical trials office over ten years. Most recently Dr. Tenaerts oversaw European operations for CoAxia, a medical device company. She received a MD degree from K.U. Leuven, Belgium, and a MBA from the University of South Florida. She sits on the expert advisory group for the MIT collaborative initiatives on the clinical trial process and is a frequent speaker on the topic of transforming Clinical Trials.